Ragini Kudchadkar, MD
- Associate Professor of Hematology & Medical Oncology, Emory University School of Medicine
- Associate Director, Hematology and Medical Oncology Fellowship Program, Emory University School of Medicine
Sponsored Research Projects
- CA209-168 Expanded Access Program with Nivolumab for Subjects with Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Systemic Treatment Containing an Anti CTLA-4 Monoclonal Antibody
- CA209-204: Study to Evaluate Safety and Efficacy in Subjects with Melanoma Metastatic to the Brain Treated With Nivolumab in Combination With Ipilimumab Followed by Nivolumab Monotherapy
- CA209-218 Expanded Access Program with Nivolumab (BMS-936558)
- CA209-238: A Phase 3, Randomized, Double-blind Study of Adjuvant Immunotherapy
- CA209-915: Phase 3 Study of Immunotherapy after resection of Stage 3 or 4 Melanoma
- MK-3475-054: A randomized, double- blind Phase 3 trial of the EORTC Melanoma Group
Program Topics
Affiliated Units
- Emory University School of Medicine
- Emory University School of Medicine